Drug intelligence / Profile preview

methylcobalamin + folic acid + pyridoxine + cholecalciferol

Development stage
Unknown
Lead developer
Invenex
Modality
Small Molecules
Administration
Oral
01

Overview

methylcobalamin + folic acid + pyridoxine + cholecalciferol is an oral combination vitamin and nutritional supplement developed by Invenex Pharma. This formulation is primarily indicated for the management of peripheral neuropathy, megaloblastic anemia, and general nutritional deficiencies. It contains methylcobalamin (1500 mcg), a bioactive coenzyme form of Vitamin B12 that supports nerve regeneration and myelin sheath formation by acting as a cofactor for methionine synthase. Folic acid (5 mg) and pyridoxine hydrochloride (3 mg) are included to facilitate DNA synthesis and neurotransmitter metabolism, respectively. Cholecalciferol (Vitamin D3, 1000 IU) is incorporated to maintain calcium homeostasis and provide neuroprotective benefits. Together, these components work synergistically to improve neurological function and metabolic health.

Brand names
INVEMETH-D3INVEMETH-D-3INVEMETH-D 3
Other names
Methylcobalamin 1500mcg + Folic acid 5mg + Pyridoxine HCL 3mg + Vitamin D3 1000 IUMethylcobalamin + Folic Acid + Pyridoxine + Vitamin D3
02

Targets

MTR (Methionine synthase)PDXK (Pyridoxal kinase)VDR (Vitamin D receptor)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on methylcobalamin + folic acid + pyridoxine + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin + folic acid + pyridoxine + cholecalciferol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call